Clin2
NCT06802861Possibly a fitRecruiting

Aspirin metabolism in pregnant women at risk of pre-eclampsia

PreeclampsiaPreeclampsia (PE)Preeclampsia (PE) RiskObesity and Obesity-related Medical ConditionsPregnancyPregnancy ComplicationsGestational DiabetesGestational Diabetes Mellitus in Pregnancy

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 45 years
Study type
Observational

Who can take part

  • Your doctor has recommended taking aspirin to lower your risk of pre-eclampsia.
  • You are willing to take aspirin as directed throughout the study.
  • You are less than 16 weeks pregnant at enrollment.
  • You can communicate comfortably in English.
  • You do not have diabetes or gestational diabetes right now.
  • You do not have a bleeding disorder or take blood thinners or NSAIDs like ibuprofen.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07565727Recruiting
Heart Health and Metabolism in Early Pregnancy

This study looks at how the body processes sugar and nutrients during pregnancy in women at higher risk for pre-eclampsia (a serious pregnancy condition with high blood pressure). Researchers want to understand if taking low-dose aspirin helps protect heart and metabolic health. You'll have blood tests, body composition scans, and metabolic measurements.

Knoxville, Tennessee
NCT06952712Not yet recruiting· Phase 3
Aspirin dose for preventing preeclampsia in high-risk obese pregnancies

This study compares two doses of aspirin (150 mg vs 100 mg) to see which is better at preventing preeclampsia, a serious pregnancy complication involving high blood pressure, in women who are obese and at higher risk. If you qualify, you would take one aspirin dose daily during pregnancy.

Guangzhou, Guangdong
NCT07665853Not yet recruiting· Phase 3
Aspirin timing study for preventing preeclampsia

This study looks at whether taking aspirin for a longer or shorter time during pregnancy can better prevent preeclampsia, a serious condition with high blood pressure. It is for pregnant women already taking daily aspirin and found to be at high risk.

Vienna
NCT05709483Recruiting· Early Phase 1
Aspirin plan test to predict who avoids preeclampsia

This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.

New York, New York
NCT07041385Not yet recruiting
Comparing aspirin doses to prevent preeclampsia in high-risk pregnancy

This trial compares two doses of aspirin (75 mg vs 150 mg) to see which is better at preventing preeclampsia in pregnant women at high risk. If you join, you'll take aspirin daily, and researchers will track your blood pressure and pregnancy health.

Lahore, Punjab Province
NCT06468202Recruiting· Phase 4
Aspirin dose study to prevent high blood pressure in pregnancy

This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.

Birmingham, Alabama

Hear when a new Preeclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.